#Congratulations to our client ArchiMed on their acquisition of Eurolyser Diagnostica, a fast-growing #Austrian#IVD player. The announcement follows ArchiMed's investment in Italy-based DIESSE diagnostica senese SpA, and marks the fund's second investment in the IVD space this year. Eurolyser Diagnostica's #pointofcare platform serves three distinct end markets: #medical diagnostics, #veterinary diagnostics, and #food & #feed. The business has grown from distinct leadership positions in both hashtag#medical and #veterinary mono tests, and it will be interesting to see how management is challenging the status quo of incumbents such as Orion Diagnostica Oy, IDEXX, and Abaxis, Inc.